A case series of endoscopic cyclophotocoagulation with 532-nm laser in Japanese patients with refractory glaucoma.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
10
03
2019
accepted:
19
06
2019
revised:
07
06
2019
pubmed:
25
7
2019
medline:
22
6
2021
entrez:
24
7
2019
Statut:
ppublish
Résumé
To report an initial case series of Japanese patients with refractory glaucoma treated with endoscopic cyclophotocoagulation (ECP) using an ECP device that was equipped with a 532-nm neodymium-doped yttrium aluminium garnet (Nd:YAG) laser. This observational case series included 10 consecutive glaucomatous eyes (7 with primary open-angle glaucoma; 3 with secondary glaucoma after cataract surgery) of 10 Japanese subjects (7 men, 3 women; mean age ± standard deviation, 65.7 ± 15.0 years) who underwent ECP to control intraocular pressure (IOP), and preserve visual function. Age, sex, glaucoma type, ocular surgical history, preoperative and postoperative logarithm of the minimum angle of resolution visual acuity (VA), IOP, number of antiglaucoma medications, perioperative complications, and treatments for complications were collected from the medical and surgical records. The IOP and numbers of antiglaucoma medications were compared between preoperative and postoperative values. The mean preoperative IOP (27.3 ± 5.4 mm Hg; range, 19-36) and number of antiglaucoma medications (4.4 ± 0.8; range, 3-6) decreased significantly by 53% and 39% ( p = 0.0005 and p = 0.0043, respectively) to 12.9 ± 5.2 mm Hg (range, 8-20) and 2.7 ± 1.4 (range, 0-4), respectively, at the final visit. Compared with preoperative values, a mixed-effect regression model showed significant decreases in the IOP and numbers of medications at every time point up to 24 months postoperatively. No phthisis bulbi or persistent hypotony was recorded. At the final visit, compared with preoperative values, the VA decreased in three eyes by >0.2 unit because of glaucoma progression. ECP with Nd:YAG laser is a reasonable option in eyes with refractory glaucoma.
Identifiants
pubmed: 31332294
doi: 10.1038/s41433-019-0538-4
pii: 10.1038/s41433-019-0538-4
pmc: PMC7042330
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
507-514Références
Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295–304.
doi: 10.1016/S0140-6736(14)62111-5
Tanito M, Ikeda Y, Fujihara E. Effectiveness and safety of combined cataract surgery and microhook ab interno trabeculotomy in Japanese eyes with glaucoma: report of an initial case series. Jpn J Ophthalmol. 2017;61:457–64.
doi: 10.1007/s10384-017-0531-z
Tanito M, Sugihara K, Hara K, Takai Y. Different glaucoma types and glaucoma surgeries among different age groups. Graefe’s Arch Clin Exp Ophthalmol. 2018;256:2013–4.
doi: 10.1007/s00417-018-4058-x
Bietti G. Surgical intervention on the ciliary body; new trends for the relief of glaucoma. JAMA. 1950;142:889–97.
doi: 10.1001/jama.1950.02910300027006
Lin P, Wollstein G, Glavas IP, Schuman JS. Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome. Ophthalmology. 2004;111:2137–43.
doi: 10.1016/j.ophtha.2004.05.027
Seibold LK, SooHoo JR, Kahook MY. Endoscopic cyclophotocoagulation. Middle East Afr J Ophthalmol. 2015;22:18–24.
doi: 10.4103/0974-9233.148344
Patel A, Thompson JT, Michels RG, Quigley HA. Endolaser treatment of the ciliary body for uncontrolled glaucoma. Ophthalmology. 1986;93:825–30.
doi: 10.1016/S0161-6420(86)33662-5
Zarbin MA, Michels RG, de Bustros S, Quigley HA, Patel A. Endolaser treatment of the ciliary body for severe glaucoma. Ophthalmology. 1988;95:1639–48.
doi: 10.1016/S0161-6420(88)32963-5
Uram M. Ophthalmic laser microendoscope endophotocoagulation. Ophthalmology. 1992;99:1829–32.
doi: 10.1016/S0161-6420(92)31717-8
Ishida K. Update on results and complications of cyclophotocoagulation. Curr Opin Ophthalmol. 2013;24:102–10.
doi: 10.1097/ICU.0b013e32835d9335
Kaplowitz K, Kuei A, Klenofsky B, Abazari A, Honkanen R. The use of endoscopic cyclophotocoagulation for moderate to advanced glaucoma. Acta Ophthalmol. 2015;93:395–401.
doi: 10.1111/aos.12529
Grover S, Fishman GA, Anderson RJ, Tozatti MS, Heckenlively JR, Weleber RG, et al. Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older. Ophthalmology. 1999;106:1780–5.
doi: 10.1016/S0161-6420(99)90342-1
Tanito M, Sano I, Ikeda Y, Fujihara E. Patch grafting using an ologen collagen matrix to manage tubal exposure in glaucoma tube shunt surgery. Case Rep Ophthalmol. 2018;9:9–16.
doi: 10.1159/000485549
Chen J, Cohn RA, Lin SC, Cortes AE, Alvarado JA. Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucomas. Am J Ophthalmol. 1997;124:787–96.
doi: 10.1016/S0002-9394(14)71696-4
Yu MB, Huang SS, Ge J, Guo J, Fang M. [The clinical study of endoscopic cyclophotocoagulation on the management of refractory glaucoma]. Zhonghua Yan Ke Za Zhi. 2006;42:27–31.
pubmed: 16638277
Murthy GJ, Murthy PR, Murthy KR, Kulkarni VV, Murthy KR. A study of the efficacy of endoscopic cyclophotocoagulation for the treatment of refractory glaucomas. Ind J Ophthalmol. 2009;57:127–32.
doi: 10.4103/0301-4738.45502
Vogel A, Dlugos C, Nuffer R, Birngruber R. Optical properties of human sclera, and their consequences for transscleral laser applications. Lasers Surg Med. 1991;11:331–40.
doi: 10.1002/lsm.1900110404
Assia EI, Hennis HL, Stewart WC, Legler UF, Carlson AN, Apple DJ. A comparison of neodymium: yttrium aluminum garnet and diode laser transscleral cyclophotocoagulation and cyclocryotherapy. Invest Ophthalmol Vis Sci. 1991;32:2774–8.
pubmed: 1894475
Pantcheva MB, Kahook MY, Schuman JS, Rubin MW, Noecker RJ. Comparison of acute structural and histopathological changes of the porcine ciliary processes after endoscopic cyclophotocoagulation and transscleral cyclophotocoagulation. Clin Exp Ophthalmol. 2007;35:270–4.
doi: 10.1111/j.1442-9071.2006.01415.x
Lin SC, Chen MJ, Lin MS, Howes E, Stamper RL. Vascular effects on ciliary tissue from endoscopic versus trans-scleral cyclophotocoagulation. Brit J Ophthalmol. 2006;90:496–500.
doi: 10.1136/bjo.2005.072777
Edmiston AM, SooHoo JR, Seibold LK, Kahook MY, Palestine AG, Pantcheva MB. Postoperative inflammation after endoscopic cyclophotocoagulation: racial distribution and effect on outcomes. J Glaucoma. 2018;27:266–8.
doi: 10.1097/IJG.0000000000000884
Cohen A, Wong SH, Patel S, Tsai JC. Endoscopic cyclophotocoagulation for the treatment of glaucoma. Surv Ophthalmol. 2017;62:357–65.
doi: 10.1016/j.survophthal.2016.09.004
Yu JY, Kahook MY, Lathrop KL, Noecker RJ. The effect of probe placement and type of viscoelastic material on endoscopic cyclophotocoagulation laser energy transmission. Ophthalmic Surg Lasers Imaging. 2008;39:133–6.
doi: 10.3928/15428877-20080301-18
Francis BA, Kawji AS, Vo NT, Dustin L, Chopra V. Endoscopic cyclophotocoagulation (ECP) in the management of uncontrolled glaucoma with prior aqueous tube shunt. J Glaucoma. 2011;20:523–7.
pubmed: 21048513
Murakami Y, Akil H, Chahal J, Dustin L, Tan J, Chopra V, et al. Endoscopic cyclophotocoagulation versus second glaucoma drainage device after prior aqueous tube shunt surgery. Clin Exp Ophthalmol. 2017;45:241–6.
doi: 10.1111/ceo.12828
Yang Y, Zhong J, Dun Z, Liu XA, Yu M. Comparison of efficacy between endoscopic cyclophotocoagulation and alternative surgeries in refractory glaucoma: a meta-analysis. Medicine. 2015;94:e1651.
doi: 10.1097/MD.0000000000001651